Journal
CANCER LETTERS
Volume 412, Issue -, Pages 143-154Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2017.10.010
Keywords
Pancreatic cancer; Pancreatic stellate cells; Leading cells; Extracellular matrix remodeling; Endo180
Categories
Funding
- Japan Society for the Promotion of Science [26108010, 26293305, 15K10185, 25713050, 16K15621, 16K10601, 16K10600, 16H05417, 15K15498, 15H04933, 16H05418]
- Grants-in-Aid for Scientific Research [17K10701, 16J03962, 15K10187] Funding Source: KAKEN
Ask authors/readers for more resources
Specific cell populations leading the local invasion of cancer are called leading cells. However, the underlying mechanisms are unclear. Here, we identified leading cells in pancreatic cancer and determined how these cells lead and promote cancer cell invasion in the extracellular matrix (ECM). Using three-dimensional matrix remodeling assay, we found that pancreatic stellate cells (PSCs) frequently invaded the collagen matrix with pancreatic cancer cells (PCCs), which invaded behind the invading PSCs. In addition, invading PSCs changed the alignment of collagen fibers, resulting in ECM remodeling and an increase in the parallel fibers along the direction of invading PSCs. Endo180 expression was higher in PSCs than in PCCs, Endo180 knockdown in PSCs attenuated the invasive abilities of PSCs and co-cultured PCCs, and decreased the expression level of phosphorylated myosin light chain 2 (MLC2). In mouse models, Endo180-knockdown PSCs suppressed tumor growth and changes in collagen fiber orientation in co-transplantation with PCCs. Our findings suggest that PSCs lead the local invasion of PCCs by physically remodeling the ECM, possibly via the function of Endo180, which reconstructs the actin cell skeleton by phosphorylation of MLC2. (C) 2017 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available